2012-11-22 16:58:29 - Asthma preventive drugs market led by GlaxoSmithKline's Advair
The asthma preventive drugs market has been forecast to increase at a compound annual growth rate (CAGR) of 4.5% through to 2015, driven by the increasing incidence of asthma along with the increased focus on contract manufacturing outsourcing.Asthma is a respiratory condition in which the airways become inflammed and constrict, usually in response to one or more environmental triggers. As a serious and potentially fatal condition if left untreated, asthma can be managed by avoiding triggers and with drug therapy.Over 300 million people suffer from asthma, which translates to a drug market worth over $15 billion.In recent years, the increase in urbanisation and changes in lifestyle have caused a sharp increase in the incidence of asthma. The increasing air pollution
is one of the main factors responsible for the increasing incidence of asthma. People are spending more time indoors. This increases their exposure to dust, mold, and other known allergens. Increased exposure to these disease-causing allergens increases the risk of developing asthma.While drugs to manage asthma have existed for several decades, pharmaceutical companies have developed faster acting and more effective products over the years. GlaxoSmithKline´s Advair and AstraZeneca´s Symbicort are the latest generation of asthma drugs, and are poised to take over the market as older products go genericIn the overall asthma preventive drugs market, Advair remained the market leader in 2011, recording a market value of US$ 7,802 million, while Singulair is the second largest drug in terms of revenue at US$5479 million.The patent that provides US market exclusivity for Singulair was expected to expire in August 2012. It is expected that within 2-3 years following patent expiration, it will lose substantially all US sales of Singulair, with most of those declines coming in the first full year following patent expiration.For more information on the asthma preventive drugs market, see the latest research: Asthma Preventive Drugs MarketFollow us on Twitter @CandMResearch
Click for news details: www.companiesandmarkets.com/News/Healthcare-and-Medical/Asthma-p ..
Browse all Healthcare and Medical C&M News www.companiesandmarkets.com/News/Healthcare-and-Medical/?aCode=f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.